Thermo Fisher Bioproduction Insights

  1. Titer Analysis In The Era Of Complex Antibody Therapeutics 3/13/2026

    As antibody formats grow more complex, titer is harder to measure. Chromatography cuts through matrix noise to deliver accurate, scalable quantification from early development through QC.

  2. The Future Of RNA Manufacturing Starts With Raw Material Innovation 2/11/2026

    Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

  3. Reframing Residual DNA Testing: What It Is--And What It Isn't 2/11/2026

    Residual host-cell DNA quantitation requires sensitive, well-validated analytical workflows to ensure accurate impurity control, process understanding, and regulatory compliance in complex biologics.

  4. Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy 2/6/2026

    The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

  5. Integrated Upstream And Downstream Strategies For Robust Manufacturing 2/5/2026

    Process robust mAb production requires understanding scale dependent cell environments, leveraging predictive models, and pursuing data driven control to minimize variability and optimize quality.

  6. High Purity Alcohols In Biopharma: Insights In Navigating Compliance 1/14/2026

    Learn how to mitigate supply chain risks for industrial alcohols and ensure workplace safety through rigorous tracking and reporting protocols.

  7. Avoid CapEX With Improved Operational Efficiencies 1/14/2026

    Avoid massive capital expenditures by optimizing supply chain logistics. Learn how off-site material sampling and just-in-time delivery reduce lead times from eight weeks to a single day.

  8. Exploring NK Cells And TILs: Emerging Strategies In Immunotherapy 11/14/2025

    Explore the rise of NK cell and TIL therapies as next-generation immunotherapies. Understand their unique benefits, limitations, and the manufacturing challenges that must be overcome for patient access.

  9. Rethinking Peptones As First-Line Optimization Tools 11/14/2025

    Peptones enhance CHO cell growth, viability, and yield, offering a fast, low-risk way to improve bioprocess performance without major process changes.

  10. Multispecific Antibodies: Key Challenges And Solutions To Enable A New Frontier In Cancer Treatment 11/14/2025

    Multispecific antibodies are a newer class of cancer therapeutics addressing tumor complexity. Learn about the design, manufacturing, and regulatory challenges and integrated solutions accelerating their development.